3.8 Article

Huntington's Disease Clinical Trials Corner: November 2022

Journal

JOURNAL OF HUNTINGTONS DISEASE
Volume 11, Issue 4, Pages 351-367

Publisher

IOS PRESS
DOI: 10.3233/JHD-229006

Keywords

Huntington disease; clinical trials

Categories

Funding

  1. Vaccinex Inc.

Ask authors/readers for more resources

This article provides an in-depth overview of the PIVOT HD and SIGNAL trials in Huntington's disease, along with a comprehensive list of all currently registered and ongoing clinical trials. It also includes a "breaking news" section highlighting recent updates on the SELECT HD, uniQure AMT-130, and VIBRANT HD clinical trials.
In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the PIVOT HD (PTC518), and SIGNAL (pepinemab) trials, and list all currently registered and ongoing clinical trials in Huntington's disease. We also introduce a `breaking news' section highlighting recent updates about the SELECT HD, uniQure AMT-130, and VIBRANT HD clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available